During the past decade, Poznański Ośrodek Medyczny NOVAMED conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Poznański Ośrodek Medyczny NOVAMED" are "Diabetes Mellitus, Type 2" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Poznański Ośrodek Medyczny NOVAMED" in a lesser frequency.

Most popular intervention types in "Poznański Ośrodek Medyczny NOVAMED" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Folic Acid" (1 trials), "Metformin" (1 trials), "Methotrexate" (1 trials) and "SC12267 (4SC-101)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Poznański Ośrodek Medyczny NOVAMED" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Poznański Ośrodek Medyczny NOVAMED". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Poznański Ośrodek Medyczny NOVAMED, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Poznański Ośrodek Medyczny NOVAMED, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".